Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stefan PoppfiledCriticalStefan Popp
Priority to RO118859ApriorityCriticalpatent/RO91766B1/en
Publication of RO91766A2publicationCriticalpatent/RO91766A2/en
Publication of RO91766B1publicationCriticalpatent/RO91766B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Metoda de tratament al enterobiozei, conform inventiei, consta în aceea ca tratamentul se face în trei reprize, în prima se administreaza, timp de 4 zile, timol conditionat în tablete, ce se dau alternativ cu tablete enterosolubile, intervalul dintre administrarile celor doua feluri de tablete fiind de 1 h, în a 5-a zi se administreaza sulfat de sodiu si vitamina C si se face o clisma apoasa cu procaina si clorura de sodiu, a 2-a repriza se face dupa 7 zile si consta în administrarea de tablete de sulf obisnuite si enterosolubile, dupa schema de mai sus, urmata de o clisma ce contine etanol, iar repriza a 3-a se face tor dupa 7 zile, cu tribromfenolat de bismut, care se administraza dupa schema de mai sus.The method of treatment of enterobiosis according to the invention consists in the fact that the treatment is done in three halves, the first is administered for 4 days, tablet-conditioned timol, alternatively with enteric-coated tablets, the interval between administrations of the two types of tablets being 1 hour, on day 5, sodium sulfate and vitamin C are administered and an aqueous enema is made with procaine and sodium chloride, the 2nd half is done after 7 days and consists of the administration of tablets sulfur and enterosoluble sulfur, according to the above scheme, followed by an ethanol-containing enema, and the third step is made after 7 days with bismuth tribromophenolate, which is administered as above.
RO118859A1985-05-241985-05-24Method for treating enterobiasis
RO91766B1
(en)
PHARMACEUTICAL COMPOUND CONTAINING 1.2.3.CARBOXYPROPIONYL OXYLETH 2 METHYL 5 NITROIMIDAZOLE AS A THERAPEUTIC PEOPLE ACTIVE AGAINST DISEASES CAUSED BY ANAEROBIC GERMS